WISeKey QuoVadis Provides Advanced Solutions for Secure Corporate Email
Sep 28, 2017 05:02 am UTC| Business
WISeKey QuoVadis Provides Advanced Solutions for Secure Corporate Email WISeKey QuoVadis has partnered with several email gateway companies including German encryption specialists Zertificon Solutions Geneva,...
Data Facts, Inc. Unveils New Fingerprinting Solution
Sep 28, 2017 05:00 am UTC| Business
MEMPHIS, Tenn., Sept. 28, 2017 -- Data Facts, Inc, a leading provider of background screening solutions, recently announced an addition to their current suite of background screening and monitoring products. Data...
Anfield Gold Announces Legal Action
Sep 28, 2017 02:30 am UTC| Business
VANCOUVER, British Columbia, Sept. 27, 2017 -- Anfield Gold Corp. (“Anfield” or “Company”) (TSXV:ANF) announces that it has determined that the Brazilian Ministério Público Federal (“MPF”) has brought an action against...
Intra-Cellular Therapies Prices $150 Million Public Offering of Common Stock
Sep 28, 2017 02:26 am UTC| Business
NEW YORK, Sept. 27, 2017 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 9,677,419 shares of its...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Xenith Bankshares Inc.
Sep 28, 2017 02:06 am UTC| Business
WILMINGTON, Del., Sept. 27, 2017 -- Rigrodsky Long, P.A.: Rigrodsky Long, P.A. announces that it has filed a class action complaint in the United States District Court for the Eastern District of Virginia on behalf...
Deciphera Pharmaceuticals Announces Pricing of Initial Public Offering
Sep 28, 2017 01:49 am UTC| Business
WALTHAM, Mass., Sept. 27, 2017 -- Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced the pricing of...
NuCana plc Announces Pricing of Initial Public Offering
Sep 28, 2017 01:36 am UTC| Business
EDINBURGH, United Kingdom, Sept. 27, 2017 -- NuCana plc (Nasdaq:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying its ProTide™...